Skip to main content
. 2014 Dec 1;9(12):e113931. doi: 10.1371/journal.pone.0113931

Figure 5. Correlation between the tumour reduction induced by sorafenib and the circulating IL-6 levels.

Figure 5

N = 20 (B16, n = 6; C26, n = 7; LLC, n = 7). Pearson Correlation. ** Correlation is statistically significant at 0,01 level (bilateral).